中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Polarized Autologous Macrophages (PAM) Can Be a Tumor Vaccine

文献类型:期刊论文

作者Wang, DQ; Chen, HY; Hu, Y
刊名ONCOLOGIE
出版日期2022
卷号24期号:3页码:441-449
ISSN号1292-3818
关键词Polarized autologous macrophages immunotherapy solid tumors vaccine hydrogel
DOI10.32604/oncologie.2022.024898
文献子类Article
英文摘要Immunotherapy is currently recognized as one of the most promising anticancer strategies. In the tumor micro -environment, tumor-associated macrophages are mainly M2-type macrophages with tumor-promoting effects. Therefore, the reprogramming of tumor-associated macrophages from M2 to M1 type is a potential strategy for cancer therapy. We have previously shown the anticancer effects of implantable allogeneic M1 macrophages in mice. Here, we further engineered autologous mouse bone marrow cells into M1 macrophages and then embedded them into a sodium alginate gel to prepare an implantable immunotherapeutic agent (M1@Gel). We demonstrate that M1@Gel repolarizes M2 macrophages to M1 type and activates the immune responses in mice. As a result, M1@Gel can potently inhibit the tumor recurrence in mice after the surgical tumor removal. These results suggest that the implantation of autologous M1 macrophages might be a promising strategy for pre-venting postoperative tumor recurrence. We envisage that the employment of polarized autologous macrophages as a tumor vaccine might be translated into clinic.
电子版国际标准刊号1765-2839
语种英语
WOS记录号WOS:000863681900005
源URL[http://ir.ihep.ac.cn/handle/311005/300061]  
专题高能物理研究所_多学科研究中心
作者单位中国科学院高能物理研究所
推荐引用方式
GB/T 7714
Wang, DQ,Chen, HY,Hu, Y. Polarized Autologous Macrophages (PAM) Can Be a Tumor Vaccine[J]. ONCOLOGIE,2022,24(3):441-449.
APA Wang, DQ,Chen, HY,&Hu, Y.(2022).Polarized Autologous Macrophages (PAM) Can Be a Tumor Vaccine.ONCOLOGIE,24(3),441-449.
MLA Wang, DQ,et al."Polarized Autologous Macrophages (PAM) Can Be a Tumor Vaccine".ONCOLOGIE 24.3(2022):441-449.

入库方式: OAI收割

来源:高能物理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。